Encephalopathy with amyloid angiopathy and numerous amyloid plaques with low levels of CSF Aβ1–40/Aβ1–42

References

• Gilles C, Brucher JM, Khoubesserian P, Vanderhaeghen JJ. Cerebral amyloid angiopathy as a cause of multiple intracerebral hemorrhages. Neurology 1984;34:730–735.
   PubMedGoogle Scholar
• Greenberg SM. Cerebral amyloid angiopathy: prospects for clinical diagnosis and treatment. Neurology 1998;51:690–694.
   PubMed Web of Science ®Google Scholar
• Osumi AK, Tien RD, Felsberg GJ, Rosenbloom M. Cerebral amyloid angiopathy presenting as a brain mass. Am J Neuroradiol 1995;16:911–915.
   PubMedGoogle Scholar
• Kinnecom C, Lev MH, Wendell L, Smith EE, Rosand J, Frosch MP, Greenberg SM. Course of cerebral amyloid angiopathy-related inflammation. Neurology 2007;68:1411–1416.
   PubMed Web of Science ®Google Scholar
• Eng JA, Frosch MP, Choi K, Rebeck GW, Greenberg SM. Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol 2004;55:250–256.
   PubMed Web of Science ®Google Scholar
• Scolding NJ, Joseph F, Kirby PA, Mazanti I, Gray F, Mikol J, Ellison D, et al. Abeta-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain 2005;128:500–515.
   PubMed Web of Science ®Google Scholar
• Hoshi K, Yoshida K, Nakamura A, Tada T, Tamaoka A, Ikeda S. Cessation of cerebral hemorrhage recurrence associated with corticosteroid treatment in a patient with cerebral amyloid angiopathy. Amyloid 2000;7:284–288.
   PubMed Web of Science ®Google Scholar
• Machida K, Tsuchiya-Suzuki A, Sano K, Arima K, Saito Y, Kametani F, Ikeda S. Postmortem findings in a patient with cerebral amyloid angiopathy actively treated with corticosteroid. Amyloid 2012;19:47–52.
   PubMed Web of Science ®Google Scholar
• Gilbert JJ, Vinters HV. Cerebral amyloid angiopathy: incidence and complications in the aging brain. I. Cerebral hemorrhage. Stroke 1983;14:915–923.
   PubMed Web of Science ®Google Scholar
• Greenberg SM, Vonsattel JP, Stakes JW, Gruber M, Finklestein SP. The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage. Neurology 1993;43:2073–2079.
   PubMed Web of Science ®Google Scholar
• Aisen PS. The potential of anti-inflammatory drugs for the treatment of Alzheimer’s disease. Lancet Neurol 2002;1:279–284.
   PubMed Web of Science ®Google Scholar
• Ikeda M, Sharma V, Sumi SM, Rogaeva EA, Poorkaj P, Sherrington R, Nee L, et al. The clinical phenotype of two missense mutations in the presenilin I gene in Japanese patients. Ann Neurol 1996;40:912–917.
   PubMedGoogle Scholar
• Wenham PR, Price WH, Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991;337:1158–1159.
   PubMed Web of Science ®Google Scholar
• Mucllan M, Crawford F, Axelman K, Houlden H, Lilius L, Winbald B, Lannfelt L. A pathogenic mutation for probable Alzheimer’s disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet 1992;1:345–347.
   PubMedGoogle Scholar
• Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 1991;349:704–706.
   PubMed Web of Science ®Google Scholar
• Ikeda M, Mizushima K, Fujita Y, Watanabe M, Sasaki A, Makioka K, Enoki M, et al. Familial amyloid polyneuropathy (Finnish type) in a Japanese family: Clinical features and immunocytochemical studies. J Neurol Sci 2007;252:4–8.
   PubMed Web of Science ®Google Scholar
• Ikeda M, Shoji M, Kawarai T, Kawarabayashi T, Matsubara E, Murakami T, Sasaki A, et al. Accumulation of filamentous tau in the cerebral cortex of human tau R406W transgenic mice. Am J Pathol 2005;166:521–531.
   PubMedGoogle Scholar
• Fukumoto H, Tokuda T, Kasai T, Ishigami N, Hidaka H, Kondo M, Allsop D, Nakagawa M. High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients. FASEB J 2010;24:2716–2726.
   PubMed Web of Science ®Google Scholar
• Kasuga K, Tokutake T, Ishikawa A, Uchiyama T, Tokuda T, Onodera O, Nishizawa M, Ikeuchi T. Differential levels of alpha-synuclein, beta-amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer’s disease. J Neurol Neurosurg Psychiatr 2010;81:608–610.
   PubMed Web of Science ®Google Scholar
• Campbell DM, Bruins S, Vogel H, Shuer LM, Wijman CA. Intracerebral hemorrhage caused by cerebral amyloid angiopathy in a 53-year-old man. J Neurol 2008;255:597–598.
   PubMedGoogle Scholar
• Biffi A, Greenberg SM. Cerebral amyloid angiopathy: a systematic review. J Clin Neurol 2011;7:1–9.
   PubMed Web of Science ®Google Scholar
• Suzuki N, Iwatsubo T, Odaka A, Ishibashi Y, Kitada C, Ihara Y. High tissue content of soluble beta 1-40 is linked to cerebral amyloid angiopathy. Am J Pathol 1994;145:452–460.
   PubMed Web of Science ®Google Scholar
• Renard D, Castelnovo G, Wacongne A, Le Floch A, Thouvenot E, Mas J, Gabelle A, et al. Interest of CSF biomarker analysis in possible cerebral amyloidangiopathy cases defined by the modified Boston criteria. J Neurol 2012 (In Press).
   Google Scholar
• Previti ML, Zhang W, Van Nostrand WE. Dexamethasone diminishes the pro-inflammatory and cytotoxic effects of amyloid beta-protein in cerebrovascular smooth muscle cells. J Neuroinflammation 2006;3:18.
   PubMedGoogle Scholar
• Kloppenborg RP, Richard E, Sprengers ME, Troost D, Eikelenboom P, Nederkoorn PJ. Steroid responsive encephalopathy in cerebral amyloid angiopathy: a case report and review of evidence for immunosuppressive treatment. J Neuroinflammation 2010;7:18.
   PubMedGoogle Scholar
• Englund H, Degerman Gunnarsson M, Brundin RM, Hedlund M, Kilander L, Lannfelt L, Pettersson FE. Oligomerization partially explains the lowering of Abeta42 in Alzheimer’s disease cerebrospinal fluid. Neurodegener Dis 2009;6:139–147.
   PubMedGoogle Scholar
• Sperling RA, Jack CR Jr, Black SE, Frosch MP, Greenberg SM, Hyman BT, Scheltens P, et al. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer’s Association Research Roundtable Workgroup. Alzheimers Dement 2011;7:367–385.
   PubMed Web of Science ®Google Scholar